ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0CUM Orphazyme A/s

61,590.00
0.00 (0.00%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Orphazyme A/s LSE:0CUM London Ordinary Share DK0062502894 ORPHAZYME ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 61,590.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 17.87M 26.07M 0.7383 121.90 3.18B

Changes to the Board of Directors

17/05/2023 11:44am

GlobeNewswire Inc.


Orphazyme A/s (LSE:0CUM)
Historical Stock Chart


From May 2023 to May 2024

Click Here for more Orphazyme A/s Charts.
Changes to the Board of Directors

Company announcement                                                                                         Orphazyme A/SNo. 07/2023                                                                                                             Ole Maaløes Vej 3DK-2200 Copenhagen N                                                                                                                                                       www.orphazyme.comCompany Registration No. 32266355

  Copenhagen, Denmark, May 17, 2023 – Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces that during the Annual General Meeting on May 17, 2023, Bo Jesper Hansen, John Sommer Schmidt and Anders Fink Vadsholt withdrew their candidacy as members of the Board of Directors.

Michael Schlomo Gabriely Hove, Jakob Færch Bendtsen and Jakob Alsted Have were elected as new members of the Board of Directors by the general meeting. A description of the qualifications and competencies of each of the new members of the Board of Directors will be appended to the company announcement regarding the result of the Annual General Meeting.

For additional information, please contact

Orphazyme A/S

Anders Vadsholt, Chief Executive Officer and Chief Financial Officer: +45 28 98 90 55

Attachment

  • Orphazyme - Company announcement

1 Year Orphazyme A/s Chart

1 Year Orphazyme A/s Chart

1 Month Orphazyme A/s Chart

1 Month Orphazyme A/s Chart

Your Recent History

Delayed Upgrade Clock